Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic update 1997-1998 (1). First part]

A J Scheen1

  • 1Département de Médecine, Université de Liège.

Revue Medicale De Liege
|November 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

This review covers new drugs for internal medicine in Belgium, focusing on cardiovascular, respiratory, digestive, and neurologic conditions. It highlights novel molecules and their clinical applications for better patient outcomes.

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Clinical Therapeutics

Context:

  • Overview of recent drug registrations and launches in Belgium.
  • Focus on internal medicine disciplines including cardiovascular, respiratory, digestive, and neurologic diseases.
  • Emphasis on the clinical relevance and practical application of new pharmaceutical agents.

Purpose:

  • To describe the most significant drugs registered and/or launched in Belgium over the past year.
  • To highlight the novelty and therapeutic originality of these molecules.
  • To provide guidance on the appropriate use of these new drugs in clinical practice.

Summary:

  • This first part details new drugs impacting cardiovascular, respiratory, digestive, and neurologic conditions.
  • The review emphasizes the unique properties and clinical utility of each new pharmaceutical agent.

Related Experiment Videos

  • It serves as a guide for healthcare professionals regarding the integration of these novel therapies.

    • Impact:

    • Facilitates informed decision-making for clinicians regarding new treatment options.
    • Enhances understanding of the latest advancements in internal medicine pharmacotherapy.
    • Supports the optimization of patient care through the appropriate use of innovative drugs.